Next-generation IV Infusion Pumps Market To Reach US$ 3.2

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
87
Next-generation IV Infusion Pumps Market To Reach US$ 3.2 Bn by 2025 – Persistence Market Research

New York, Sept. 25, 2017 (GLOBE NEWSWIRE) --

Persistence Market Research has carried out a detailed market research on next-generation IV infusion pumps and has presented vital insights based on the market analyses in its research publication titled “Next-Generation IV Infusion Pumps Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)”. This research report covers various macro-economic aspects influencing the growth of the next generation IV infusion pumps market along with various trends, opportunities, restraints and drivers impacting the market. These impacting factors are scrutinized across important regions considering all major market segments.

The global next-generation IV infusion pumps market has been thoroughly analyzed and is anticipated to grow at a robust CAGR of 5.4% throughout the period of forecast 2017-2025. The global market is estimated to reach a value of about US$ 3.2 Bn in 2025 from a value of around US$ 2 Bn in 2016. This market has witnessed a positive growth path since 2012 and it is poised to continue over the following years.

Global Market Research Report Overview on Next-generation IV Infusion Pumps @ https://www.persistencemarketresearch.com/mar...market.asp

Expanding production base for smart PCA, ambulatory and syringe pumps in developing economies and rising adoption of smart pumps with huge drug libraries are opportunities that can be tapped by players involved in the global next-generation IV infusion pumps market. Emerging economies offer high opportunities as they register high rate of spread of chronic diseases. The advancements in IV infusion pumps systems, increasing research and development infrastructure due to rising investments and expenditure on research and development, favorable reimbursement for infusion therapy, rising demand for ambulatory infusion pumps, increasing strategic collaborations among leading players, improvement in distribution channel, ease in FDA approvals and clearance, strong government support for start-ups, expanding production capacity and extension of product line coupled with expanding medical device infrastructure and growing adoption of advanced medical devices have strongly supported the growth of the next-generation IV infusion pumps market. Medicine dispensing errors, product recalls due to product errors, lack of skilled personnel and lack of standard usage guidelines are few aspects which pull the adoption of next-generation IV infusion pumps thus having a negative impact on the global next-generation IV infusion pumps market.

A sample of this report is available upon request@ https://www.persistencemarketresearch.com/samples/15781

Global Next-Generation IV Infusion Pumps Market: Segmental Highlights

The global next-generation IV infusion pumps market has been categorized by product type, by application, by end user and by region.

By region, Asia Pacific is expected to witness high growth as compared to other regions, and is poised to reach a significant market share with a high CAGR of 7.8% throughout the period of forecast 2017-2025. North America region stays ahead with respect to market value to dominate the global next-generation IV infusion pumps market by region followed by Europe.

Chemotherapy segment by application is the fastest growing segment and is expected to reflect high market valuation by the end of 2025. This segment is projected to grow at a CAGR of 7.1% throughout the forecast period to attain an estimated value of about US$ 1.1 Bn in 2025.

Hospitals segment by end user dominates the global market and also poised to reflect a high CAGR of 6.0% during the assessment period due to rise in adoption of infusion pumps in hospitals.

Large volumetric infusion systems to lead the global next-generation IV infusion pumps market by product type to reach a market value of about US$ 1.1 Bn in 2025. Electronic ambulatory infusion systems product segment is poised to show high potential in the coming years.

View Report Table of Contents, Figures, and Tables@ https://www.persistencemarketresearch.com/mar...market/toc  

Global Next-Generation IV Infusion Pumps Market: Competitive Landscape

The global next-generation IV infusion pumps market research report covers key players involved in the  market such as B. Braun Melsungen AG., Becton, Dickinson Company, Fresenius Kabi AG, Terumo Corporation, Medtronic Plc., Baxter International Inc., Hospira, Inc., iRadimed Corporation, Zyno Medical, Nipro Corporation, Ambu A/S, Summit Medical Products, Inc., Smiths Medical, vTitan and Gamastech s.r.l.

Global Next-generation IV Infusion Pumps Market Report is Available for US$ 4,900

Persistence Market Research Overview Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Persistence Market Research U.S. Sales Office: 305 Broadway, 7th Floor New York City, NY 10007 +1-646-568-7751 United States USA - Canada Toll-Free: 800-961-0353 Email: sales@persistencemarketresearch.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 11

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 5

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 3

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading

Top 5 Most Recently Viewed Articles

Encore Capital Group Prepares for First Quarter Release

Updated Category News Views 354

Encore Capital Group to Report Q1 2025 Financial Results Encore Capital Group, Inc. (Nasdaq:ECPG) is setting the stage for its financial results announcement for the first quarter of the year. This highly anticipated event will take place on a Wednesday in early May. Stakeholders and the public alike are invited to tune in as important financial metrics will be shared,...

Continue Reading
Corteva's Q3 Success and Updated 2025 Financial Outlook

Updated Category News Views 242

Overview of Corteva's Financial Performance Corteva, Inc. (NYSE: CTVA) has recently made headlines with strong financial performance, having reported positive results for the third quarter and for the year-to-date 2025. As a leading entity in the agricultural sector, Corteva attributes its performance to robust volume growth in both its Crop Protection and Seed segments....

Continue Reading
Insights from Ring Energy's Latest Sustainability Report

Updated Category News Views 337

Overview of Ring Energy's 2024 Sustainability Report Ring Energy, Inc. has officially released its latest sustainability report for 2024, reflecting its ongoing commitment to transparency and responsible practices. This report marks the fourth successive annual update, showcasing the company's dedication to advancing Environmental, Social, and Governance (ESG)...

Continue Reading
Tesla's Rising Sales Amid Intense Competition from Rivals

Updated Category News Views 188

Tesla's Sales Surge Amidst Growing Competition Tesla Inc (NASDAQ: TSLA) has recently seen a remarkable increase in its electric vehicle (EV) sales in China, demonstrating its ability to thrive in a highly competitive market. In August, Tesla achieved its best sales month in 2024, driven by impressive sales figures. However, the company faces challenges as BYD Company...

Continue Reading
Bitcoin Bancorp's Strategic Leap with NASDAQ Ticker 'BCBC'

Updated Category News Views 114

Bitcoin Bancorp Announces NASDAQ Ticker Reservation Bitcoin Bancorp (Ticker: BULT), formerly known as Bullet Blockchain, Inc., has recently made waves in the financial sphere by securing the reservation of the NASDAQ ticker symbol 'BCBC'. This strategic move marks a significant step in the company’s ambitious plan to uplist to NASDAQ, further amplifying its presence in...

Continue Reading